NovoCure Limited (NVCR) Gross margin 2017–2026
NovoCure Limited (NVCR) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.5%FY2026 · since FY2017: 44.2% → 74.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 74.5% | -2.8 pp |
| FY2025 | 77.3% | +2.5 pp |
| FY2024 | 74.8% | -3.8 pp |
| FY2023 | 78.6% | +0.1 pp |
| FY2022 | 78.5% | +0.1 pp |
| FY2021 | 78.5% | +3.7 pp |
| FY2020 | 74.8% | +7.0 pp |
| FY2019 | 67.7% | -0.9 pp |
| FY2018 | 68.6% | +24.4 pp |
| FY2017 | 44.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NVCR financial trends
NVCR RevenueNVCR Net incomeNVCR Net marginNVCR Gross profitNVCR Operating incomeNVCR Operating marginNVCR Operating cash flowNVCR Free cash flowNVCR Capital expendituresNVCR Return on equityNVCR Stock buybacksNVCR Dividends paidNVCR Total assetsNVCR Total liabilitiesNVCR Shareholders’ equityNVCR overview →